Matches in Wikidata for { <http://www.wikidata.org/entity/Q66027746> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q66027746 description "clinical trial" @default.
- Q66027746 description "ensayu clínicu" @default.
- Q66027746 description "klinisch onderzoek" @default.
- Q66027746 description "клінічне випробування" @default.
- Q66027746 name "A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies." @default.
- Q66027746 name "A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies." @default.
- Q66027746 type Item @default.
- Q66027746 label "A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies." @default.
- Q66027746 label "A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies." @default.
- Q66027746 prefLabel "A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies." @default.
- Q66027746 prefLabel "A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies." @default.
- Q66027746 P1132 Q66027746-E5A50C34-1DA0-45B9-A282-9246FF4FBF76 @default.
- Q66027746 P1476 Q66027746-20E25080-7947-4989-B904-E6446A25C6F0 @default.
- Q66027746 P17 Q66027746-1F2DD47A-1C06-439E-8097-BCFE80796C4B @default.
- Q66027746 P17 Q66027746-38E52A9A-5540-4CCB-9966-CAD41F3B6F51 @default.
- Q66027746 P17 Q66027746-40505EEF-C1EF-4FB0-B2B6-FD469AB948E1 @default.
- Q66027746 P17 Q66027746-D6501179-960C-46F4-AC8C-1E837DE18ED4 @default.
- Q66027746 P17 Q66027746-E5E5A2A3-35A1-4DC5-9FB1-33ACEAE0C596 @default.
- Q66027746 P2899 Q66027746-6C6961E4-59FA-4C80-A8B2-CC7D84D4D495 @default.
- Q66027746 P3098 Q66027746-EE08536F-78C9-4882-A040-F7B8D6D5367B @default.
- Q66027746 P31 Q66027746-D660709C-A67E-4BF4-B212-A5CB75569E1A @default.
- Q66027746 P4844 Q66027746-E3E07D08-2980-451F-A90F-B60C8DCEEFCA @default.
- Q66027746 P580 Q66027746-A98D163D-3D27-43CE-B57C-D95FFE81B2A8 @default.
- Q66027746 P582 Q66027746-6EEC701F-9B75-4C65-B359-7278C9D7600F @default.
- Q66027746 P6099 Q66027746-5582B60D-09C5-4863-A822-F0C49E09F9CA @default.
- Q66027746 P6153 Q66027746-0EC1A166-1F9F-473F-81AC-991C0A60D7DB @default.
- Q66027746 P8363 Q66027746-E4100A77-6115-4B9B-A914-CBA803B89A70 @default.
- Q66027746 P859 Q66027746-E6222926-4E29-450D-BD83-B106F928AED2 @default.
- Q66027746 P1132 "+384" @default.
- Q66027746 P1476 "An International, Randomized, Double-Blind, Placebo-Controlled, Multicenter, 6-Month Study of the Efficacy and Safety of Valtrex 1g QD vs. Placebo for the Suppression of HSV-2 Genital Herpes in Newly Diagnosed Immunocompetent Patients" @default.
- Q66027746 P17 Q155 @default.
- Q66027746 P17 Q16 @default.
- Q66027746 P17 Q298 @default.
- Q66027746 P17 Q30 @default.
- Q66027746 P17 Q414 @default.
- Q66027746 P2899 "+18" @default.
- Q66027746 P3098 "NCT00158860" @default.
- Q66027746 P31 Q30612 @default.
- Q66027746 P4844 Q418594 @default.
- Q66027746 P580 "2004-06-21T00:00:00Z" @default.
- Q66027746 P582 "2006-07-26T00:00:00Z" @default.
- Q66027746 P6099 Q42825046 @default.
- Q66027746 P6153 Q212322 @default.
- Q66027746 P8363 Q78089383 @default.
- Q66027746 P859 Q212322 @default.